Intravenous Alteplase for acute ischemic stroke in patients with current malignant neoplasm
Authors:
- Manuel CappellariMCManuel Cappellari
- Monica CarlettiMCMonica Carletti
- Nicola MichelettiNMNicola Micheletti
- Giampaolo TomelleriGTGiampaolo Tomelleri
- Domenico AjenaDADomenico Ajena
- Giuseppe MorettoGMGiuseppe Moretto
- Paolo BoviPBPaolo Bovi
- 1 February 2013
- journal article
- Published by Elsevier in Journal of the Neurological Sciences
- Vol. 325 (1-2) , 100-102
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Off‐label intravenous thrombolysis in acute strokeEuropean Journal of Neurology, 2011
- Risk of Thrombolytic Therapy for Acute Ischemic Stroke in Patients With Current MalignancyJournal of Stroke and Cerebrovascular Diseases, 2011
- Intravenous thrombolysis for acute stroke in patients with cancerJournal of Neurology, Neurosurgery & Psychiatry, 2010
- Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen ActivatorStroke, 2009
- Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic StrokeNew England Journal of Medicine, 2008
- Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational studyThe Lancet, 2007
- Prothrombotic states that predispose to strokeCurrent Treatment Options in Neurology, 2002
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Classification and natural history of clinically identifiable subtypes of cerebral infarctionThe Lancet, 1991